Compare PRDO & PAHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRDO | PAHC |
|---|---|---|
| Founded | 1994 | 1946 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.7B |
| IPO Year | 1997 | 2014 |
| Metric | PRDO | PAHC |
|---|---|---|
| Price | $33.26 | $54.74 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 1 | 3 |
| Target Price | ★ $42.00 | $34.33 |
| AVG Volume (30 Days) | ★ 468.9K | 287.7K |
| Earning Date | 05-22-2026 | 05-06-2026 |
| Dividend Yield | ★ 1.80% | 0.88% |
| EPS Growth | 10.50 | ★ 1883.33 |
| EPS | ★ 2.42 | 1.32 |
| Revenue | $581,296,000.00 | ★ $833,350,000.00 |
| Revenue This Year | $5.51 | $17.03 |
| Revenue Next Year | N/A | $3.82 |
| P/E Ratio | ★ $13.78 | $41.40 |
| Revenue Growth | N/A | ★ 4.12 |
| 52 Week Low | $23.87 | $16.16 |
| 52 Week High | $38.02 | $56.30 |
| Indicator | PRDO | PAHC |
|---|---|---|
| Relative Strength Index (RSI) | 60.96 | 71.01 |
| Support Level | $30.93 | $37.09 |
| Resistance Level | $34.60 | $56.30 |
| Average True Range (ATR) | 0.99 | 1.94 |
| MACD | 0.17 | 0.09 |
| Stochastic Oscillator | 80.49 | 77.28 |
Perdoceo Education Corp is an American for-profit education company that focuses on quality postsecondary education online to a diverse student population, along with campus-based and blended learning programs. The company's important segments include the American InterContinental University, the University of St. Augustine for Health Sciences, and Colorado Technical University. These universities provide undergraduate, graduate, and doctoral degree programs focusing on business, technology, management, and social services, with the majority of the students enrolled in programs offered fully online. The majority of the company's revenue comes from the Colorado Technical University segment.
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.